U.S., Oct. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07218783) titled 'Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhine)' on Oct. 16.
Brief Summary: This trial is a randomized study to evaluate the Bimatoprost Implant System used in combination with the SpyGlass IOL to Timolol Ophthalmic Solution in participants with mild to moderate open-angle glaucoma or ocular hypertension undergoing cataract surgery.
Study Start Date: Oct. 15
Study Type: INTERVENTIONAL
Condition:
Cataract
Glaucoma
Ocular Hypertension
Intervention:
DRUG: Bimatoprost Implant System
Bimatoprost Implant System used in ...